Roux-en-Y Gastric Bypass and Sleeve Gastrectomy: Mechanisms of Diabetes Remission and Role of Gut Hormones
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
CONTEXT: In obese patients with type 2 diabetes (T2DM), Roux-en-Y-gastric-bypass (RYGB) and sleeve gastrectomy (SLG) improve glycemic control. OBJECTIVE: The objective of this study was to investigate the mechanisms of surgery-induced T2DM improvement and role of gastrointestinal hormones. PATIENTS, SETTING, AND INTERVENTION: In 35 patients with T2DM, we performed a mixed-meal test before and 15 days and 1 year after surgery (23 RYGB and 12 SLG). MAIN OUTCOME MEASURES: Insulin sensitivity, β-cell function, and amylin, ghrelin, PYY, pancreatic polypeptide (PP), glucagon, and glucagon-like peptide-1 (GLP-1) responses to the meal were measured. RESULTS: T2DM remission occurred in 13 patients undergoing RYGB and in 7 patients undergoing SLG. Similarly in the RYGB and SLG groups, β-cell glucose sensitivity improved both early and long term (P < .005), whereas insulin sensitivity improved long term only (P < .006), in proportion to body mass index changes (P < .001). Early after RYGB, glucagon and GLP-1 responses to the meal increased, whereas the PP response decreased. At 1 year, PYY was increased, and PP, amylin, ghrelin, and GLP-1 were reduced. After SLG, hormonal responses were similar to those with RYGB except that PP was increased, whereas amylin was unchanged. In remitters, fasting GLP-1 was higher (P = .04), but its meal response was flat compared with that of nonremitters; postsurgery, however, the GLP-1 response was higher. Other hormone responses were similar between the 2 groups. In logistic regression, presurgery β-cell glucose sensitivity (positive, P < .0001) and meal-stimulated GLP-1 response (negative, P = .004) were the only predictors of remission. CONCLUSIONS: RYGB and SLG have a similar impact on diabetes remission, of which baseline β-cell glucose sensitivity and a restored GLP-1 response are the chief determinants. Other hormonal responses are the consequences of the altered gastrointestinal anatomy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 16×
“Results: T2DM remission occurred in 13 patients undergoing RYGB and in 7 patients undergoing SLG. Similarly in the RYGB and SLG groups, -cell glucose sensitivity improved both early and long term (P .005), whereas insulin sensitivity improved long term only (P .006), in proportion to body mass index changes (P .001).”
BackgroundMethodResultInfluentialReduced incretin effect in Type 2 (non-insulin dependent) diabetes
Nauck, M., Stöckmann, F., Ebert, R., & Creutzfeldt, W. (1986) · Diabetologia · doi:10.1007/bf02427280 · Cited by 1,307 · cited 2×
“Fasting amylin, pg mL 1 83 (42) 80 (40) 38 (18) 38 (38) 36 (28) 38 (11) Fasting ghrelin, pg mL 1 32 (14) 28 (25) 24 (16) 26 (5) 25 (3) 12 (12) Fasting PP, pg mL 1b 66 (44) 72 (69) 86 (80) 64 (141) 102 (162) 154 (242) Fasting PYY, pg mL 1 75 (61) 71 (59) 119 (72) 58 (43) 63 (38) 69 (82) Fasting glucagon, pg mL 1 60 (22…”
BackgroundCauter, E. V., Mestrez, F., Sturis, J., & Polonsky, K. S. (1992) · Diabetes · doi:10.2337/diab.41.3.368 · Cited by 890
Vilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
Karamanakos, S. N., Vagenas, K., Kalfarentzos, F., & Alexandrides, T. K. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318156f012 · Cited by 813
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects
Carlsson, L. M. S., Peltonen, M., Ahlin, S., Anveden, Å., Bouchard, C., Carlsson, B., Jacobson, P., Lönroth, H., Maglio, C., Näslund, I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112082 · Cited by 794
Peterli, R., Wölnerhanssen, B., Peters, T., Devaux, N., Kern, B., Christoffel-Courtin, C., Drewe, J., von Flüe, M., & Beglinger, C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181ae32e3 · Cited by 565
Ferrannini, E. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.4.0336 · Cited by 451 · cited 6×
“The -cell function model consists of 3 blocks: (1) a model for fitting the glucose concentration profile, the purpose of which is to smooth and interpolate plasma glucose concentrations; (2) a model describing the dependence of insulin (or C-peptide) secretion on the glucose concentration; and (3) a model of C-peptide…”
BackgroundMethodInfluentialSelf-citationHormonal and Metabolic Mechanisms of Diabetes Remission after Gastrointestinal Surgery
Thaler, J. P., & Cummings, D. E. (2009) · Endocrinology · doi:10.1210/en.2009-0367 · Cited by 443
Bariatric Surgery Versus Intensive Medical Therapy in Obese Patients With Diabetes
Schauer, P. R., Kashyap, S. R., Wolski, K., Brethauer, S. A., Kirwan, J. P., Pothier, C. E., Thomas, S., Abood, B., Nissen, S. E., & Bhatt, D. L. (2013) · Survey of Anesthesiology · doi:10.1097/sa.0b013e31827f316e · Cited by 410
Weyer, C., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.1.89 · Cited by 357
Meal and oral glucose tests for assessment of β-cell function: modeling analysis in normal subjects
Mari, A., Schmitz, O., Gastaldelli, A., Oestergaard, T., Nyholm, B., & Ferrannini, E. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00093.2002 · Cited by 303
Self-citationMetabolic Effects of Bariatric Surgery in Patients With Moderate Obesity and Type 2 Diabetes
Kashyap, S. R., Bhatt, D. L., Wolski, K., Watanabe, R. M., Abdul-Ghani, M., Abood, B., Pothier, C. E., Brethauer, S., Nissen, S., Gupta, M., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1596 · Cited by 286
Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes
Holst, J. J., Knop, F. K., Vilsbøll, T., Krarup, T., & Madsbad, S. (2011) · Diabetes Care · doi:10.2337/dc11-s227 · Cited by 280
A New Paradigm for Type 2 Diabetes Mellitus: Could It Be a Disease of the Foregut?
Hickey, M. S., Pories, W. J., MacDonald, K. G., Cory, K. A., Dohm, G. L., Swanson, M. S., Israel, R. G., Barakat, H. A., Considine, R. V., Caro, J. F., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199805000-00004 · Cited by 275
Vidal, J., Ibarzabal, A., Romero, F., Delgado, S., Momblán, D., Flores, L., & Lacy, A. (2008) · Obesity Surgery · doi:10.1007/s11695-008-9547-2 · Cited by 272
Braghetto, I., Davanzo, C., Korn, O., Csendes, A., Valladares, H., Herrera, E., Gonzalez, P., & Papapietro, K. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9954-z · Cited by 255
Calanna, S., Christensen, M., Holst, J. J., Laferrère, B., Gluud, L. L., Vilsbøll, T., & Knop, F. K. (2013) · Diabetologia · doi:10.1007/s00125-013-2841-0 · Cited by 251 · cited 2×
“It should be noted that, according to a recent meta-analysis (34), GLP-1 responses in type 2 diabetes are quite variable, perhaps as a function of the patient’s phenotype but also because of other factors, including impaired secretion (35, 36), accelerated metabolism of GLP-1 (37), and defective responsiveness to GLP-…”
BackgroundReduced Time Points to Calculate the Composite Index
DeFronzo, R. A., & Matsuda, M. (2010) · Diabetes Care · doi:10.2337/dc10-0646 · Cited by 240
Impaired regulation of the incretin effect in patients with type 2 diabetes
Bagger, J. I., Knop, F. K., Lund, A., Vestergaard, H., Holst, J. J., & Vilsbøll, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2435 · Cited by 219
Narrative Review: Effect of Bariatric Surgery on Type 2 Diabetes Mellitus
Vetter, M. L., Cardillo, S., Rickels, M. R., & Iqbal, N. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00007 · Cited by 192
Dirksen, C., Damgaard, M., Bojsen‐Møller, K. N., Jørgensen, N. B., Kielgast, U., Jacobsen, S. H., Naver, L. S., Worm, D., Holst, J. J., Madsbad, S., et al. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12087 · Cited by 184 · cited 1×
“After RYGB, the bulk of foods pass without hindrance into the small intestine, whereas small intestinal transit is prolonged (24); similar data have been reported after SLG.”
BackgroundRamón, J. M., Salvans, S., Crous, X., Puig, S., Goday, A., Benaiges, D., Trillo, L., Pera, M., & Grande, L. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-1855-0 · Cited by 181
Nannipieri, M., Mari, A., Anselmino, M., Baldi, S., Barsotti, E., Guarino, D., Camastra, S., Bellini, R., Berta, R. D., & Ferrannini, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0446 · Cited by 178
Self-citationRomero, F., Nicolau, J., Flores, L., Casamitjana, R., Ibarzabal, A., Lacy, A., & Vidal, J. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2166-y · Cited by 165
Lee, W.-J., Chen, C.-Y., Chong, K., Lee, Y.-C., Chen, S.-C., & Lee, S.-D. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.07.009 · Cited by 164
Umeda, L. M., Silva, E. A., Carneiro, G., Arasaki, C. H., Geloneze, B., & Zanella, M. T. (2011) · Obesity Surgery · doi:10.1007/s11695-011-0412-3 · Cited by 137
Keidar, A., Hershkop, K. J., Marko, L., Schweiger, C., Hecht, L., Bartov, N., Kedar, A., & Weiss, R. (2013) · Diabetologia · doi:10.1007/s00125-013-2965-2 · Cited by 131
Ghrelin Regulates Insulin Release and Glycemia: Physiological Role and Therapeutic Potential
Yada, T., Dezaki, K., Sone, H., Koizumi, M., Boldbaatar, D., Nakata, M., & Kakei, M. (2008) · Current Diabetes Reviews · doi:10.2174/157339908783502352 · Cited by 121
BOSE, M., TEIXEIRA, J., OLIVAN, B., BAWA, B., ARIAS, S., MACHINENI, S., PI‐SUNYER, F. X., SCHERER, P. E., & LAFERRÈRE, B. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2009.00064.x · Cited by 119
Scott, W. R., & Batterham, R. L. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00038.2011 · Cited by 100
The Gut Hormone Response Following Roux-en-Y Gastric Bypass: Cross-sectional and Prospective Study
Pournaras, D. J., Osborne, A., Hawkins, S. C., Mahon, D., Ghatei, M. A., Bloom, S. R., Welbourn, R., & le Roux, C. W. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9989-1 · Cited by 94
Chen, C., Fujimiya, M., Laviano, A., Chang, F.-Y., Lin, H., & Lee, S. (2010) · Journal of the Chinese Medical Association · doi:10.1016/s1726-4901(10)70048-4 · Cited by 72
Boey, D., Heilbronn, L. K., Sainsbury, A., Laybutt, D. R., Kriketos, A. D., Herzog, H., & Campbell, L. V. (2006) · Neuropeptides · doi:10.1016/j.npep.2006.08.002 · Cited by 68
Maki, K. C., Rains, T. M., Dicklin, M. R., & Bell, M. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0083 · Cited by 33
Comparison Between RYGB, DS, and VSG Effect on Glucose Homeostasis
Roslin, M. S., Dudiy, Y., Weiskopf, J., Damani, T., & Shah, P. C. (2012) · Obesity Surgery · doi:10.1007/s11695-012-0686-0 · Cited by 32
Cited by
Steinert, R. E., Feinle-Bisset, C., Asarian, L., Horowitz, M., Beglinger, C., & Geary, N. (2017) · Physiological Reviews · doi:10.1152/physrev.00031.2014 · Cited by 578
Physiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Mechanisms of changes in glucose metabolism and bodyweight after bariatric surgery
Madsbad, S., Dirksen, C., & Holst, J. J. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70218-3 · Cited by 298
Ganesan, K., Chung, S. K., Vanamala, J., & Xu, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123720 · Cited by 221
“On the other hand, GPR41 activate peptide YY (PYY), an intestinal hormone that influences gut motility, enhances intestinal transit rate, and decreases energy harvest from the diet [139].”
BackgroundMiras, A. D., Pérez-Pevida, B., Aldhwayan, M., Kamocka, A., McGlone, E. R., Al-Najim, W., Chahal, H., Batterham, R. L., McGowan, B., Khan, O., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30157-3 · Cited by 190
Metadata
- Authors
- Nannipieri, M., Baldi, S., Mari, A., Colligiani, D., Guarino, D., Camastra, S., Barsotti, E., Berta, R., Moriconi, D., Bellini, R., Anselmino, M., & Ferrannini, E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-11
- Volume
- 98
- Issue
- 11
- Pages
- 4391-4399
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2113671838
- Cited by
- 293
- References
- 36
- FWCI
- 28.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.